Equities

Curvebeam AI Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Curvebeam AI Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.078
  • Today's Change-0.002 / -2.50%
  • Shares traded254.14k
  • 1 Year change-42.22%
  • Beta--
Data delayed at least 20 minutes, as of Feb 16 2026 03:07 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

CurveBeam AI Limited combines point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI) expertise to deliver solutions across orthopedics and bone health (fragility fracture prevention). Its products include HiRise, LineUp, PedCAT Premium, pedCAT, InReach, OssView, CubeVue Software, Autometrics, 3D Measurement Tools and Cloud. HiRise is a bilateral, weight-bearing CT imaging of the entire lower extremities including hips/pelvis and distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach is a point-of-care extremity CT imaging for the upper extremities and the non-weight bearing lower extremities. InReach HR-pQCT is a high-resolution peripheral quantitative CT (HR-pQCT) imaging designed for the point-of-care. OssView is a bone fragility software that analyzes HR-pQCT images at the distal radius to measure the bone microarchitecture.

  • Revenue in AUD (TTM)12.10m
  • Net income in AUD-16.84m
  • Incorporated2009
  • Employees50.00
  • Location
    Curvebeam AI Ltd2800 Bronze Dr, Suite 110HATFIELD 19440United StatesUSA
  • Phone+1 (267) 483-8081
  • Websitehttps://curvebeamai.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Resonance Health Ltd11.16m-1.73m20.42m18.00--2.11--1.83-0.0038-0.00380.02450.02040.5848--3.82---9.08-4.17-12.91-4.98-----15.53-9.03---6.570.2882--26.7824.65-1,123.59--19.97--
Control Bionics Ltd7.04m-6.11m23.07m----3.06--3.28-0.0232-0.02320.02610.01830.81584.993.35---70.78-48.07-99.30-55.8071.1468.24-86.77-98.271.08-33.300.0733--16.7616.36-3.30--7.93--
ImExHS Ltd26.35m-4.11m24.32m400.00--1.67--0.9232-0.0861-0.08610.55920.26931.1877.603.3265,869.38-18.42-17.16-27.27-22.8834.4432.57-15.61-21.021.51-10.770.0863--34.4127.4741.00---9.90--
CONNEQT Health Ltd3.55m-18.19m26.94m26.00--38.21--7.58-0.0507-0.05070.010.00120.32350.438910.72---165.59-99.31-618.20-249.1671.9784.29-511.88-208.530.6557-2.370.8527---68.20-5.10-168.93---33.92--
Genetic Signatures Ltd21.36m-20.10m29.53m----0.5895--1.38-0.0899-0.08990.09420.22050.35051.176.04---32.98-16.72-35.71-18.3156.7255.89-94.10-38.679.49-143.040.0156--49.698.55-12.55---17.43--
Atomo Diagnostics Ltd3.79m-4.97m32.41m----4.24--8.55-0.0077-0.00770.00590.00940.36721.072.83---48.13-30.62-57.46-33.1050.6240.54-131.08-113.092.27--0.0259---10.53-6.7227.41---55.73--
ImpediMed Ltd12.72m-23.24m36.70m77.00--1.78--2.88-0.0115-0.01150.00630.01010.28712.165.51165,246.80-52.43-42.33-59.33-48.4986.2585.16-182.62-195.144.71-112.780.4142--23.3117.25-17.42---14.47--
Curvebeam AI Ltd12.10m-16.84m38.22m50.00--0.8839--3.16-0.0453-0.04530.03230.09050.19460.634310.20---27.10---31.21--44.89---139.24--1.22-80.930.3366--85.33--27.09------
BCAL Diagnostics Ltd2.65m-7.24m44.17m----7.06--16.67-0.0201-0.02010.00740.0170.239--0.9573---65.31-57.98-87.92-72.00-----273.21-249.54----0.2766---13.0143.11-13.14--190.46--
HeraMED Ltd322.93k-4.53m44.55m----60.80--137.94-0.0059-0.00590.00040.00070.13810.37941.57---193.87-129.03-316.53-221.1458.7058.67-1,404.05-2,178.902.33--0.468---39.9011.7418.96------
Nova Eye Medical Ltd29.27m-9.06m47.00m130.00--2.47--1.61-0.0373-0.03730.11830.06681.042.927.08---32.13-21.38-39.78-24.9764.5478.66-30.95-46.441.85-121.420.1372--24.8117.95-3.06---14.69--
Cleanspace Holdings Ltd19.76m-478.27k50.16m----2.61113.572.54-0.0062-0.00620.25380.24480.73721.954.94---1.78-6.87-2.07-8.2974.7674.57-2.42-10.494.46--0.1914--25.72-6.9984.71---23.72--
Vitasora Health Ltd3.71m-10.11m50.17m2.00--2.90--13.54-0.0071-0.00710.00270.00930.30130.01064.17---82.17-118.94-115.44-176.5499.1978.72-272.73-533.630.6694--0.0039--256.7710.92-41.74------
Data as of Feb 16 2026. Currency figures normalised to Curvebeam AI Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.